Cutler Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Hold |
|
|||||
|
2023
Q4 | – | Hold |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $69K | Hold |
|
|||||
|
2023
Q1 | $77K | Sell |
|
|||||
|
2022
Q4 | $222K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $172K | Buy |
|
|||||
|
2022
Q1 | – | Hold |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $167K | Sell |
|
|||||
|
2021
Q2 | $206K | Buy |
|
|||||
|
2021
Q1 | $7K | Sell |
|
|||||
|
2020
Q4 | $484K | Buy |
|
|||||
|
2020
Q3 | $91K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $169K | Buy |
|
|||||
|
2019
Q4 | $160K | Buy |
|
|||||
|
2019
Q3 | $6K | Sell |
|
|||||
|
2019
Q2 | $590K | Buy |
|
|||||
|
2019
Q1 | $208K | Sell |
|
|||||
|
2018
Q4 | $1.75M | Buy |
|
|||||
|
2018
Q3 | $1.08M | Buy |
|
|||||
|
2018
Q2 | $711K | Buy |
|
|||||
|
2018
Q1 | $533K | Sell |
|
|||||
|
2017
Q4 | $1.12M | Sell |
|
|||||
|
2017
Q3 | $1.22M | Buy |
|
|||||
|
2017
Q2 | $562K | Sell |
|
|||||
|
2017
Q1 | $1.96M | Buy |
|
|||||
|
2016
Q4 | $865K | Sell |
|
|||||
|
2016
Q3 | $2.76M | Buy |
|
|||||
|
2016
Q2 | $1.12M | Sell |
|
|||||
|
2016
Q1 | $1.46M | Buy |
|
|||||
|
2015
Q4 | $299K | Buy |
|